Trial Profile
RETROSPECTIVE COHORT STUDY OF THE NATURAL HISTORY OF TYPE 1 SPINAL MUSCULAR ATROPHY USING MEDICAL RECORD DATA
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 14 Dec 2021
Price :
$35
*
At a glance
- Drugs Risdiplam (Primary)
- Indications Spinal muscular atrophy
- Focus Therapeutic Use
- Sponsors Chugai Pharmaceutical; Roche
- 05 Oct 2018 New trial record